ACTION · 101SK202
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, randomized, double-blind, placebo-controlled, dose-finding, parallel-group study evaluating the safety and efficacy of intravenous natalizumab (BG00002) in acute ischaemic stroke. EudraCT: 2015-004783-11.
Sponsor: BIOGEN
Phase: II
Area: Neuroimmunology